These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
298 related articles for article (PubMed ID: 19059456)
1. Inhibition of mammalian thioredoxin reductase by black tea and its constituents: implications for anticancer actions. Du Y; Wu Y; Cao X; Cui W; Zhang H; Tian W; Ji M; Holmgren A; Zhong L Biochimie; 2009 Mar; 91(3):434-44. PubMed ID: 19059456 [TBL] [Abstract][Full Text] [Related]
2. Inhibitory effect of green tea extract and (-)-epigallocatechin-3-gallate on mammalian thioredoxin reductase and HeLa cell viability. Wang Y; Zhang H; Holmgren A; Tian W; Zhong L Oncol Rep; 2008 Dec; 20(6):1479-87. PubMed ID: 19020731 [TBL] [Abstract][Full Text] [Related]
3. Human selenium-dependent thioredoxin reductase from HeLa cells: properties of forms with differing heparin affinities. Gorlatov SN; Stadtman TC Arch Biochem Biophys; 1999 Sep; 369(1):133-42. PubMed ID: 10462449 [TBL] [Abstract][Full Text] [Related]
4. Hypericins and thioredoxin reductase: Biochemical and docking studies disclose the molecular basis for effective inhibition by naphthodianthrones. Sorrentino F; Karioti A; Gratteri P; Rigobello MP; Scutari G; Messori L; Bindoli A; Chioccioli M; Gabbiani C; Bergonzi MC; Bilia AR Bioorg Med Chem; 2011 Jan; 19(1):631-41. PubMed ID: 21106380 [TBL] [Abstract][Full Text] [Related]
5. Inhibition of Mammalian thioredoxin reductase by some flavonoids: implications for myricetin and quercetin anticancer activity. Lu J; Papp LV; Fang J; Rodriguez-Nieto S; Zhivotovsky B; Holmgren A Cancer Res; 2006 Apr; 66(8):4410-8. PubMed ID: 16618767 [TBL] [Abstract][Full Text] [Related]
6. Sublethal concentrations of diverse gold compounds inhibit mammalian cytosolic thioredoxin reductase (TrxR1). Omata Y; Folan M; Shaw M; Messer RL; Lockwood PE; Hobbs D; Bouillaguet S; Sano H; Lewis JB; Wataha JC Toxicol In Vitro; 2006 Sep; 20(6):882-90. PubMed ID: 16510263 [TBL] [Abstract][Full Text] [Related]
7. Substrate and inhibitor specificities differ between human cytosolic and mitochondrial thioredoxin reductases: Implications for development of specific inhibitors. Rackham O; Shearwood AM; Thyer R; McNamara E; Davies SM; Callus BA; Miranda-Vizuete A; Berners-Price SJ; Cheng Q; Arnér ES; Filipovska A Free Radic Biol Med; 2011 Mar; 50(6):689-99. PubMed ID: 21172426 [TBL] [Abstract][Full Text] [Related]
8. The role of thioredoxin reductase activity in selenium-induced cytotoxicity. Madeja Z; Sroka J; Nyström C; Björkhem-Bergman L; Nordman T; Damdimopoulos A; Nalvarte I; Eriksson LC; Spyrou G; Olsson JM; Björnstedt M Biochem Pharmacol; 2005 Jun; 69(12):1765-72. PubMed ID: 15935149 [TBL] [Abstract][Full Text] [Related]
9. Mechanistic insights into the inhibitory effects of palmitoylation on cytosolic thioredoxin reductase and thioredoxin. Qin H; Liang W; Xu Z; Ye F; Li X; Zhong L Biochimie; 2015 Mar; 110():25-35. PubMed ID: 25576832 [TBL] [Abstract][Full Text] [Related]
10. Mammalian thioredoxin reductase: oxidation of the C-terminal cysteine/selenocysteine active site forms a thioselenide, and replacement of selenium with sulfur markedly reduces catalytic activity. Lee SR; Bar-Noy S; Kwon J; Levine RL; Stadtman TC; Rhee SG Proc Natl Acad Sci U S A; 2000 Mar; 97(6):2521-6. PubMed ID: 10688911 [TBL] [Abstract][Full Text] [Related]
11. Thioredoxin reductase is irreversibly modified by curcumin: a novel molecular mechanism for its anticancer activity. Fang J; Lu J; Holmgren A J Biol Chem; 2005 Jul; 280(26):25284-90. PubMed ID: 15879598 [TBL] [Abstract][Full Text] [Related]
12. Effect of thioredoxin reductase 1 on glucocorticoid receptor activity in human outer root sheath cells. Sohn KC; Jang S; Choi DK; Lee YS; Yoon TJ; Jeon EK; Kim KH; Seo YJ; Lee JH; Park JK; Kim CD Biochem Biophys Res Commun; 2007 May; 356(3):810-5. PubMed ID: 17382897 [TBL] [Abstract][Full Text] [Related]
13. Statins inhibit expression of thioredoxin reductase 1 in rat and human liver and reduce tumour development. Skogastierna C; Johansson M; Parini P; Eriksson M; Eriksson LC; Ekström L; Björkhem-Bergman L Biochem Biophys Res Commun; 2012 Jan; 417(3):1046-51. PubMed ID: 22222370 [TBL] [Abstract][Full Text] [Related]
14. Ethaselen: a potent mammalian thioredoxin reductase 1 inhibitor and novel organoselenium anticancer agent. Wang L; Yang Z; Fu J; Yin H; Xiong K; Tan Q; Jin H; Li J; Wang T; Tang W; Yin J; Cai G; Liu M; Kehr S; Becker K; Zeng H Free Radic Biol Med; 2012 Mar; 52(5):898-908. PubMed ID: 22210352 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of thioredoxin reductase by mansonone F analogues: Implications for anticancer activity. Liu Z; Huang SL; Li MM; Huang ZS; Lee KS; Gu LQ Chem Biol Interact; 2009 Jan; 177(1):48-57. PubMed ID: 18822278 [TBL] [Abstract][Full Text] [Related]
16. Inhibitory effects of black tea theaflavin derivatives on 12-O-tetradecanoylphorbol-13-acetate-induced inflammation and arachidonic acid metabolism in mouse ears. Huang MT; Liu Y; Ramji D; Lo CY; Ghai G; Dushenkov S; Ho CT Mol Nutr Food Res; 2006 Feb; 50(2):115-22. PubMed ID: 16404705 [TBL] [Abstract][Full Text] [Related]
17. Differential regulation of expression of cytosolic and mitochondrial thioredoxin reductase in rat liver and kidney. Crosley LK; Méplan C; Nicol F; Rundlöf AK; Arnér ES; Hesketh JE; Arthur JR Arch Biochem Biophys; 2007 Mar; 459(2):178-88. PubMed ID: 17291446 [TBL] [Abstract][Full Text] [Related]
18. Inhibitory nitrosylation of mammalian thioredoxin reductase 1: Molecular characterization and evidence for its functional role in cellular nitroso-redox imbalance. Engelman R; Ziv T; Arnér ESJ; Benhar M Free Radic Biol Med; 2016 Aug; 97():375-385. PubMed ID: 27377780 [TBL] [Abstract][Full Text] [Related]
19. Cancer prevention by tea polyphenols is linked to their direct inhibition of antiapoptotic Bcl-2-family proteins. Leone M; Zhai D; Sareth S; Kitada S; Reed JC; Pellecchia M Cancer Res; 2003 Dec; 63(23):8118-21. PubMed ID: 14678963 [TBL] [Abstract][Full Text] [Related]
20. Strong inhibitory effects of common tea catechins and bioflavonoids on the O-methylation of catechol estrogens catalyzed by human liver cytosolic catechol-O-methyltransferase. Nagai M; Conney AH; Zhu BT Drug Metab Dispos; 2004 May; 32(5):497-504. PubMed ID: 15100171 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]